

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 6.32259781 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 6.05531070 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95918165 |
| 4 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.84480220 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.76692262 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.61904639 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.55420490 |
| 8 | cerebellar granule cell differentiation (GO:0021707) | 5.36042294 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.32360965 |
| 10 | cerebellar Purkinje cell layer development (GO:0021680) | 5.29428000 |
| 11 | glutamate secretion (GO:0014047) | 5.12088134 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.08467969 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.04829013 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.98964476 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.83433152 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81434128 |
| 17 | * protein localization to synapse (GO:0035418) | 4.80363466 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 4.68663404 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.59123643 |
| 20 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.58221246 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.57213387 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.55013662 |
| 23 | exploration behavior (GO:0035640) | 4.54882469 |
| 24 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52967074 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.52684770 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.50528255 |
| 27 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.47782806 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.37196230 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.36343870 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.33173488 |
| 31 | biotin metabolic process (GO:0006768) | 4.30153156 |
| 32 | iron ion import (GO:0097286) | 4.28143351 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 4.22219616 |
| 34 | import into cell (GO:0098657) | 4.12619905 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 4.10735041 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 4.08565304 |
| 37 | long-term memory (GO:0007616) | 4.05450077 |
| 38 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 4.04644091 |
| 39 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03126916 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.00285614 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.98266499 |
| 42 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.88511171 |
| 43 | * positive regulation of membrane potential (GO:0045838) | 3.85305418 |
| 44 | * regulation of synaptic plasticity (GO:0048167) | 3.83660896 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83414951 |
| 46 | sodium ion export (GO:0071436) | 3.82419438 |
| 47 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.81628688 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.78549812 |
| 49 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.78428098 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.76785615 |
| 51 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.74181970 |
| 52 | proline transport (GO:0015824) | 3.72928782 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.72635738 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.71793329 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.71260932 |
| 56 | neuron recognition (GO:0008038) | 3.70321264 |
| 57 | L-amino acid import (GO:0043092) | 3.61943027 |
| 58 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.59738238 |
| 59 | neurotransmitter transport (GO:0006836) | 3.56435463 |
| 60 | L-serine metabolic process (GO:0006563) | 3.56352294 |
| 61 | negative regulation of glycogen metabolic process (GO:0070874) | 3.55309115 |
| 62 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.52925161 |
| 63 | striatum development (GO:0021756) | 3.51221092 |
| 64 | neuromuscular process controlling balance (GO:0050885) | 3.49424856 |
| 65 | startle response (GO:0001964) | 3.43311798 |
| 66 | auditory behavior (GO:0031223) | 3.41028949 |
| 67 | prepulse inhibition (GO:0060134) | 3.39601272 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 3.37045345 |
| 69 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.36056672 |
| 70 | behavioral defense response (GO:0002209) | 3.35803221 |
| 71 | behavioral fear response (GO:0001662) | 3.35803221 |
| 72 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35578890 |
| 73 | postsynaptic membrane organization (GO:0001941) | 3.35054351 |
| 74 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31521438 |
| 75 | response to histamine (GO:0034776) | 3.31276533 |
| 76 | cellular potassium ion homeostasis (GO:0030007) | 3.30654824 |
| 77 | * learning (GO:0007612) | 3.30647766 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 3.30180064 |
| 79 | neuronal ion channel clustering (GO:0045161) | 3.29756996 |
| 80 | response to auditory stimulus (GO:0010996) | 3.29525647 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.28790638 |
| 82 | activation of protein kinase A activity (GO:0034199) | 3.28470110 |
| 83 | amino acid import (GO:0043090) | 3.28199861 |
| 84 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.27640055 |
| 85 | beta-amyloid metabolic process (GO:0050435) | 3.27188702 |
| 86 | behavioral response to cocaine (GO:0048148) | 3.26257209 |
| 87 | potassium ion import (GO:0010107) | 3.25283541 |
| 88 | presynaptic membrane assembly (GO:0097105) | 3.24448412 |
| 89 | regulation of dendritic spine development (GO:0060998) | 3.24420766 |
| 90 | axonal fasciculation (GO:0007413) | 3.23500428 |
| 91 | membrane hyperpolarization (GO:0060081) | 3.23357775 |
| 92 | * membrane depolarization (GO:0051899) | 3.23073143 |
| 93 | regulation of synapse maturation (GO:0090128) | 3.22700192 |
| 94 | potassium ion homeostasis (GO:0055075) | 3.21006914 |
| 95 | positive regulation of synaptic transmission (GO:0050806) | 3.20189188 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 3.20048430 |
| 97 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.19597703 |
| 98 | synapse assembly (GO:0007416) | 3.18618390 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 3.18579484 |
| 100 | regulation of glutamate secretion (GO:0014048) | 3.17592881 |
| 101 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14355886 |
| 102 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.13971894 |
| 103 | regulation of neurotransmitter transport (GO:0051588) | 3.12583032 |
| 104 | dendrite morphogenesis (GO:0048813) | 3.11316395 |
| 105 | neuromuscular process (GO:0050905) | 3.11210476 |
| 106 | intraspecies interaction between organisms (GO:0051703) | 3.11036821 |
| 107 | social behavior (GO:0035176) | 3.11036821 |
| 108 | regulation of female receptivity (GO:0045924) | 3.10922825 |
| 109 | * regulation of synaptic transmission (GO:0050804) | 3.09825541 |
| 110 | positive regulation of dendritic spine development (GO:0060999) | 3.08977234 |
| 111 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07539746 |
| 112 | synaptic transmission (GO:0007268) | 3.07438065 |
| 113 | presynaptic membrane organization (GO:0097090) | 3.07395060 |
| 114 | dendritic spine organization (GO:0097061) | 3.06695401 |
| 115 | fear response (GO:0042596) | 3.04546248 |
| 116 | detection of calcium ion (GO:0005513) | 3.04236408 |
| 117 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.02872130 |
| 118 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01472417 |
| 119 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.01092812 |
| 120 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00892598 |
| 121 | epithelial cell maturation (GO:0002070) | 2.98869389 |
| 122 | cell differentiation in hindbrain (GO:0021533) | 2.98537135 |
| 123 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.96383717 |
| 124 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.90010556 |
| 125 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.86046083 |
| 126 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.85285729 |
| 127 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.75177224 |
| 128 | apical protein localization (GO:0045176) | 2.73586376 |
| 129 | cellular response to electrical stimulus (GO:0071257) | 2.73408125 |
| 130 | positive regulation of histone deacetylation (GO:0031065) | 2.68469983 |
| 131 | neurotransmitter catabolic process (GO:0042135) | 2.68025782 |
| 132 | cell communication by electrical coupling (GO:0010644) | 2.62628324 |
| 133 | anterior/posterior axis specification, embryo (GO:0008595) | 2.61012263 |
| 134 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.60895688 |
| 135 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.59800281 |
| 136 | dicarboxylic acid transport (GO:0006835) | 2.58779154 |
| 137 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.58692619 |
| 138 | regulation of receptor binding (GO:1900120) | 2.54131447 |
| 139 | serotonin metabolic process (GO:0042428) | 2.52924996 |
| 140 | cellular sodium ion homeostasis (GO:0006883) | 2.52185721 |
| 141 | membrane repolarization during action potential (GO:0086011) | 2.52079283 |
| 142 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.51417674 |
| 143 | protein import into peroxisome matrix (GO:0016558) | 2.48737047 |
| 144 | cell communication involved in cardiac conduction (GO:0086065) | 2.48191873 |
| 145 | respiratory system process (GO:0003016) | 2.42797952 |
| 146 | * visual learning (GO:0008542) | 2.40217391 |
| 147 | negative regulation of glucose import (GO:0046325) | 2.39672191 |
| 148 | replicative senescence (GO:0090399) | 2.39381273 |
| 149 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.38568500 |
| 150 | membrane repolarization (GO:0086009) | 2.38248453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.50830061 |
| 2 | AR_21909140_ChIP-Seq_LNCAP_Human | 4.19545481 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.93670037 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.26171380 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.20702358 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14580897 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.77051008 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75997974 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75997974 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.73368072 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70617800 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.67022217 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60953982 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54696219 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.54115379 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52620108 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50754881 |
| 18 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 2.46050354 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44696804 |
| 20 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27699317 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26968006 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.21361906 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20220757 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18367499 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.11955556 |
| 26 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.98718236 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97840361 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94708937 |
| 29 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.94511014 |
| 30 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.94511014 |
| 31 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.94511014 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91347819 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89456172 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82869367 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82336062 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82238270 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82136965 |
| 38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.81645755 |
| 39 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.75178290 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73030421 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70910612 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.70279375 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65679904 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59576543 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.56857247 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55746682 |
| 47 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52992289 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51112099 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.49822450 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48225292 |
| 51 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.47492408 |
| 52 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44377690 |
| 53 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.42636767 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40583666 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40161704 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38535097 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36559913 |
| 58 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33255075 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31890636 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30888513 |
| 61 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30089101 |
| 62 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29921059 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29601386 |
| 64 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.29534516 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28769587 |
| 66 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28247627 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27350923 |
| 68 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26950044 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26768024 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26472184 |
| 71 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26013992 |
| 72 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24172146 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22241357 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21568355 |
| 75 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20798289 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20575549 |
| 77 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20500294 |
| 78 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20281342 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20257107 |
| 80 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16497251 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15362468 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14689401 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13893406 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12503597 |
| 85 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.11937596 |
| 86 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.11699077 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10894753 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10655992 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10033031 |
| 90 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09664641 |
| 91 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08701087 |
| 92 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08388128 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07842668 |
| 94 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07675482 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07637369 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07348957 |
| 97 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06412882 |
| 98 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06312969 |
| 99 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06151244 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05992978 |
| 101 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03840296 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02647663 |
| 103 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02388821 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02047654 |
| 105 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01625816 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01495303 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01021967 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00847223 |
| 109 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00310955 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00142189 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99457390 |
| 112 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99104970 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98837390 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98707242 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98482894 |
| 116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98090301 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97761214 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97477043 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96923768 |
| 120 | JUN_21703547_ChIP-Seq_K562_Human | 0.96769928 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95798250 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94718223 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94034039 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93984004 |
| 125 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.93574408 |
| 126 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.93115398 |
| 127 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93103111 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91800816 |
| 129 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91125731 |
| 130 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90745854 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90550249 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90259843 |
| 133 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.90209837 |
| 134 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90077102 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90033670 |
| 136 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89197339 |
| 137 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88686319 |
| 138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88599887 |
| 139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88599887 |
| 140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88331079 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87865678 |
| 142 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.85844048 |
| 143 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.84352066 |
| 144 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83910219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.91026987 |
| 2 | MP0003880_abnormal_central_pattern | 4.87428763 |
| 3 | MP0002822_catalepsy | 4.47412844 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.39323921 |
| 5 | MP0003123_paternal_imprinting | 3.86690709 |
| 6 | MP0004270_analgesia | 3.65505123 |
| 7 | MP0009745_abnormal_behavioral_response | 3.64378314 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.56267706 |
| 9 | * MP0002064_seizures | 3.27410830 |
| 10 | MP0009046_muscle_twitch | 3.02936596 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.98688972 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.97456836 |
| 13 | MP0001486_abnormal_startle_reflex | 2.71153586 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.62055230 |
| 15 | MP0002272_abnormal_nervous_system | 2.61709007 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.59445616 |
| 17 | MP0002009_preneoplasia | 2.55599176 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.53057447 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.43435922 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.34070835 |
| 21 | MP0002736_abnormal_nociception_after | 2.31405002 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.11676434 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.00714745 |
| 24 | MP0001970_abnormal_pain_threshold | 1.96466367 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.92914203 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.87392224 |
| 27 | MP0003121_genomic_imprinting | 1.86415702 |
| 28 | MP0008569_lethality_at_weaning | 1.84251389 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.79446445 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.78886710 |
| 31 | MP0004924_abnormal_behavior | 1.78886710 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.78640388 |
| 33 | MP0004858_abnormal_nervous_system | 1.77831240 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.76191750 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.74805295 |
| 36 | MP0000778_abnormal_nervous_system | 1.74127173 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.73814009 |
| 38 | MP0002184_abnormal_innervation | 1.71472066 |
| 39 | MP0003329_amyloid_beta_deposits | 1.69532568 |
| 40 | MP0003879_abnormal_hair_cell | 1.66954307 |
| 41 | MP0001529_abnormal_vocalization | 1.60408009 |
| 42 | MP0001984_abnormal_olfaction | 1.58657541 |
| 43 | MP0000955_abnormal_spinal_cord | 1.47901774 |
| 44 | MP0003315_abnormal_perineum_morphology | 1.45359569 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.42768792 |
| 46 | MP0003787_abnormal_imprinting | 1.41238760 |
| 47 | MP0003283_abnormal_digestive_organ | 1.39217686 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.39117901 |
| 49 | MP0005647_abnormal_sex_gland | 1.36659469 |
| 50 | MP0003941_abnormal_skin_development | 1.36263387 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.35981409 |
| 52 | MP0004885_abnormal_endolymph | 1.34284786 |
| 53 | MP0003633_abnormal_nervous_system | 1.28259654 |
| 54 | MP0000534_abnormal_ureter_morphology | 1.24189068 |
| 55 | MP0001188_hyperpigmentation | 1.21110358 |
| 56 | MP0002249_abnormal_larynx_morphology | 1.19710711 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.17657201 |
| 58 | MP0008057_abnormal_DNA_replication | 1.16910030 |
| 59 | MP0001905_abnormal_dopamine_level | 1.16138738 |
| 60 | MP0004142_abnormal_muscle_tone | 1.14453659 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.13668706 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.12057691 |
| 63 | MP0002152_abnormal_brain_morphology | 1.09981062 |
| 64 | MP0003631_nervous_system_phenotype | 1.09589926 |
| 65 | MP0005451_abnormal_body_composition | 1.09149310 |
| 66 | MP0001177_atelectasis | 1.06053450 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.03884832 |
| 68 | MP0008874_decreased_physiological_sensi | 1.00819688 |
| 69 | MP0008872_abnormal_physiological_respon | 0.99097612 |
| 70 | MP0000751_myopathy | 0.98395978 |
| 71 | MP0000566_synostosis | 0.98020025 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.96190805 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.93158936 |
| 74 | MP0003075_altered_response_to | 0.92012484 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.91875389 |
| 76 | MP0009672_abnormal_birth_weight | 0.91720579 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.88317332 |
| 78 | MP0003122_maternal_imprinting | 0.87552800 |
| 79 | MP0002229_neurodegeneration | 0.87335769 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.87136330 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.87109375 |
| 82 | MP0004085_abnormal_heartbeat | 0.86306955 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.86071760 |
| 84 | MP0004742_abnormal_vestibular_system | 0.85531231 |
| 85 | MP0009250_abnormal_appendicular_skeleto | 0.85150875 |
| 86 | MP0002090_abnormal_vision | 0.81035893 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.80631876 |
| 88 | MP0000579_abnormal_nail_morphology | 0.80436671 |
| 89 | MP0005187_abnormal_penis_morphology | 0.79328139 |
| 90 | MP0003690_abnormal_glial_cell | 0.79278665 |
| 91 | MP0005535_abnormal_body_temperature | 0.79048182 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.78799181 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.78220148 |
| 94 | MP0005310_abnormal_salivary_gland | 0.78106780 |
| 95 | MP0003634_abnormal_glial_cell | 0.77728280 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.76871221 |
| 97 | MP0003942_abnormal_urinary_system | 0.75940150 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.75054314 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.74981962 |
| 100 | MP0003632_abnormal_nervous_system | 0.74671405 |
| 101 | MP0005499_abnormal_olfactory_system | 0.74421528 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.74421528 |
| 103 | MP0000604_amyloidosis | 0.74083338 |
| 104 | MP0002006_tumorigenesis | 0.73912534 |
| 105 | MP0003011_delayed_dark_adaptation | 0.72541626 |
| 106 | MP0000747_muscle_weakness | 0.72492793 |
| 107 | MP0000920_abnormal_myelination | 0.72165183 |
| 108 | MP0004484_altered_response_of | 0.71933692 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.71403062 |
| 110 | MP0005409_darkened_coat_color | 0.70194762 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.69900989 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.69054536 |
| 113 | MP0002081_perinatal_lethality | 0.67675963 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.66460012 |
| 115 | MP0000026_abnormal_inner_ear | 0.65420788 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.64825478 |
| 117 | MP0000613_abnormal_salivary_gland | 0.64375661 |
| 118 | MP0001664_abnormal_digestion | 0.63013736 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.62135395 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.62129855 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.60032299 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.57828660 |
| 123 | MP0004510_myositis | 0.56169650 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.56050543 |
| 125 | MP0001943_abnormal_respiration | 0.55422517 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.54715398 |
| 127 | MP0003861_abnormal_nervous_system | 0.54038252 |
| 128 | MP0010769_abnormal_survival | 0.53978609 |
| 129 | MP0010770_preweaning_lethality | 0.51823647 |
| 130 | MP0002082_postnatal_lethality | 0.51823647 |
| 131 | MP0003956_abnormal_body_size | 0.50766069 |
| 132 | MP0010768_mortality/aging | 0.50584572 |
| 133 | MP0004233_abnormal_muscle_weight | 0.50179396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.58373270 |
| 2 | Myokymia (HP:0002411) | 7.61907409 |
| 3 | Focal seizures (HP:0007359) | 6.16113686 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.15898782 |
| 5 | Visual hallucinations (HP:0002367) | 5.15660012 |
| 6 | Atonic seizures (HP:0010819) | 4.68715941 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.36728918 |
| 8 | Febrile seizures (HP:0002373) | 4.34935472 |
| 9 | Sparse lateral eyebrow (HP:0005338) | 4.33658800 |
| 10 | Absence seizures (HP:0002121) | 4.31289990 |
| 11 | Dialeptic seizures (HP:0011146) | 4.07653089 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.06088683 |
| 13 | Neonatal hypoglycemia (HP:0001998) | 4.05860054 |
| 14 | Hyperventilation (HP:0002883) | 4.01255649 |
| 15 | Broad-based gait (HP:0002136) | 3.80169301 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.65298956 |
| 17 | Abnormality of the axillary hair (HP:0100134) | 3.63083287 |
| 18 | Abnormality of secondary sexual hair (HP:0009888) | 3.63083287 |
| 19 | Poor eye contact (HP:0000817) | 3.61912150 |
| 20 | Action tremor (HP:0002345) | 3.61841632 |
| 21 | Impaired social interactions (HP:0000735) | 3.55550997 |
| 22 | Abnormal social behavior (HP:0012433) | 3.55550997 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.50295581 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.30281755 |
| 25 | Depression (HP:0000716) | 3.26658308 |
| 26 | Ankle clonus (HP:0011448) | 3.22141638 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.20819435 |
| 28 | Papilledema (HP:0001085) | 3.18235068 |
| 29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.17511829 |
| 30 | Truncal ataxia (HP:0002078) | 3.15728357 |
| 31 | Dysmetria (HP:0001310) | 3.15645635 |
| 32 | Overgrowth (HP:0001548) | 3.14143832 |
| 33 | Anxiety (HP:0000739) | 3.08013078 |
| 34 | Amblyopia (HP:0000646) | 3.01578565 |
| 35 | Mutism (HP:0002300) | 3.00555515 |
| 36 | Postural instability (HP:0002172) | 2.94806428 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.94072726 |
| 38 | Torticollis (HP:0000473) | 2.93202147 |
| 39 | Progressive inability to walk (HP:0002505) | 2.92159375 |
| 40 | Excessive salivation (HP:0003781) | 2.91068929 |
| 41 | Drooling (HP:0002307) | 2.91068929 |
| 42 | Gonadotropin excess (HP:0000837) | 2.87848995 |
| 43 | Germ cell neoplasia (HP:0100728) | 2.83324090 |
| 44 | Focal dystonia (HP:0004373) | 2.82549114 |
| 45 | Scanning speech (HP:0002168) | 2.79989472 |
| 46 | Calf muscle hypertrophy (HP:0008981) | 2.69818051 |
| 47 | Genetic anticipation (HP:0003743) | 2.68337216 |
| 48 | Urinary urgency (HP:0000012) | 2.68114255 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.65550728 |
| 50 | Abnormality of the fingertips (HP:0001211) | 2.65089953 |
| 51 | Stereotypic behavior (HP:0000733) | 2.61954473 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.59348359 |
| 53 | Absent speech (HP:0001344) | 2.57208735 |
| 54 | Long palpebral fissure (HP:0000637) | 2.51724286 |
| 55 | Spastic gait (HP:0002064) | 2.51433162 |
| 56 | Impaired vibratory sensation (HP:0002495) | 2.50597230 |
| 57 | Shallow orbits (HP:0000586) | 2.50072654 |
| 58 | Abnormality of the lower motor neuron (HP:0002366) | 2.48145802 |
| 59 | Status epilepticus (HP:0002133) | 2.46206946 |
| 60 | Craniofacial dystonia (HP:0012179) | 2.46035079 |
| 61 | Hemiparesis (HP:0001269) | 2.45468360 |
| 62 | Bradykinesia (HP:0002067) | 2.45064779 |
| 63 | Generalized myoclonic seizures (HP:0002123) | 2.44649821 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44324410 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.43240443 |
| 66 | Inability to walk (HP:0002540) | 2.42410522 |
| 67 | Glossoptosis (HP:0000162) | 2.42298090 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.42283657 |
| 69 | Diplopia (HP:0000651) | 2.42283657 |
| 70 | Termporal pattern (HP:0011008) | 2.41370748 |
| 71 | Insidious onset (HP:0003587) | 2.41370748 |
| 72 | Annular pancreas (HP:0001734) | 2.36757112 |
| 73 | Intention tremor (HP:0002080) | 2.35353983 |
| 74 | Resting tremor (HP:0002322) | 2.34916655 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.32648684 |
| 76 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.32132056 |
| 77 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31630067 |
| 78 | Homocystinuria (HP:0002156) | 2.28213504 |
| 79 | Abnormality of homocysteine metabolism (HP:0010919) | 2.28213504 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.27513253 |
| 81 | Dysmetric saccades (HP:0000641) | 2.26262994 |
| 82 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.24967076 |
| 83 | Polyphagia (HP:0002591) | 2.24674921 |
| 84 | Testicular atrophy (HP:0000029) | 2.24213267 |
| 85 | Fetal akinesia sequence (HP:0001989) | 2.23716685 |
| 86 | Hyperacusis (HP:0010780) | 2.23446845 |
| 87 | Precocious puberty (HP:0000826) | 2.22108507 |
| 88 | Hemiplegia (HP:0002301) | 2.18476335 |
| 89 | Anal stenosis (HP:0002025) | 2.15608467 |
| 90 | Megalencephaly (HP:0001355) | 2.12785786 |
| 91 | Protruding tongue (HP:0010808) | 2.11531765 |
| 92 | Prostate neoplasm (HP:0100787) | 2.11481304 |
| 93 | Incomplete penetrance (HP:0003829) | 2.11329820 |
| 94 | Obstructive sleep apnea (HP:0002870) | 2.05598714 |
| 95 | Ankyloglossia (HP:0010296) | 2.03602748 |
| 96 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.03510585 |
| 97 | Depressed nasal tip (HP:0000437) | 2.03169425 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.02675522 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.02405503 |
| 100 | Abnormality of the corticospinal tract (HP:0002492) | 2.01855723 |
| 101 | Choanal stenosis (HP:0000452) | 2.00320471 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00046132 |
| 103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00046132 |
| 104 | Sporadic (HP:0003745) | 1.99889646 |
| 105 | Limb dystonia (HP:0002451) | 1.99651385 |
| 106 | Lower limb amyotrophy (HP:0007210) | 1.99617786 |
| 107 | Blue irides (HP:0000635) | 1.99558367 |
| 108 | Pointed chin (HP:0000307) | 1.98844133 |
| 109 | Abnormality of the parathyroid morphology (HP:0011766) | 1.97472698 |
| 110 | Gait ataxia (HP:0002066) | 1.96490354 |
| 111 | Abnormality of salivation (HP:0100755) | 1.91827224 |
| 112 | Azoospermia (HP:0000027) | 1.91577343 |
| 113 | Shawl scrotum (HP:0000049) | 1.90202341 |
| 114 | Neoplasm of the adrenal cortex (HP:0100641) | 1.90181651 |
| 115 | Inappropriate behavior (HP:0000719) | 1.87755361 |
| 116 | Limb ataxia (HP:0002070) | 1.87111318 |
| 117 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.85066258 |
| 118 | Skin pits (HP:0100276) | 1.84525731 |
| 119 | Astrocytoma (HP:0009592) | 1.83888823 |
| 120 | Abnormality of the astrocytes (HP:0100707) | 1.83888823 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.83693417 |
| 122 | Retinal dysplasia (HP:0007973) | 1.83289092 |
| 123 | Hepatoblastoma (HP:0002884) | 1.82643716 |
| 124 | Pheochromocytoma (HP:0002666) | 1.80620078 |
| 125 | Hyperglycinuria (HP:0003108) | 1.80297542 |
| 126 | Death in childhood (HP:0003819) | 1.80061833 |
| 127 | Abnormal EKG (HP:0003115) | 1.78592777 |
| 128 | Specific learning disability (HP:0001328) | 1.77509140 |
| 129 | Abnormality of chromosome segregation (HP:0002916) | 1.76323896 |
| 130 | Macroorchidism (HP:0000053) | 1.75728500 |
| 131 | Psychosis (HP:0000709) | 1.74667666 |
| 132 | Abnormality of saccadic eye movements (HP:0000570) | 1.73910938 |
| 133 | Tented upper lip vermilion (HP:0010804) | 1.73599320 |
| 134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72805713 |
| 135 | Insomnia (HP:0100785) | 1.72182004 |
| 136 | Clonus (HP:0002169) | 1.71626133 |
| 137 | Delusions (HP:0000746) | 1.71014791 |
| 138 | Bronchomalacia (HP:0002780) | 1.70964779 |
| 139 | Aplasia of the musculature (HP:0100854) | 1.70837586 |
| 140 | Rigidity (HP:0002063) | 1.70734175 |
| 141 | Intellectual disability, profound (HP:0002187) | 1.69961947 |
| 142 | Gait imbalance (HP:0002141) | 1.68510469 |
| 143 | Abnormally folded helix (HP:0008544) | 1.68412004 |
| 144 | Abnormality of glycine metabolism (HP:0010895) | 1.68394483 |
| 145 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.68394483 |
| 146 | Sleep apnea (HP:0010535) | 1.68383329 |
| 147 | Lip pit (HP:0100267) | 1.67916491 |
| 148 | Lower limb asymmetry (HP:0100559) | 1.67343971 |
| 149 | Rapidly progressive (HP:0003678) | 1.67286058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.01229428 |
| 2 | NTRK3 | 4.70467755 |
| 3 | CAMK1D | 3.79296761 |
| 4 | MAP3K9 | 3.61492903 |
| 5 | MAP3K4 | 3.14863184 |
| 6 | MARK1 | 2.96047005 |
| 7 | MAP2K7 | 2.73227119 |
| 8 | MINK1 | 2.57065810 |
| 9 | TNK2 | 2.40888717 |
| 10 | DAPK2 | 2.37389329 |
| 11 | MAP3K12 | 2.32172006 |
| 12 | CASK | 2.28275876 |
| 13 | EEF2K | 2.19052812 |
| 14 | KSR2 | 2.16523465 |
| 15 | TAF1 | 2.09077626 |
| 16 | NTRK2 | 2.06811622 |
| 17 | TRIB3 | 2.03777424 |
| 18 | PAK6 | 2.01937450 |
| 19 | MAP2K4 | 2.00823617 |
| 20 | PRKD3 | 1.90349070 |
| 21 | TNIK | 1.89070759 |
| 22 | KSR1 | 1.85471370 |
| 23 | RIPK4 | 1.84792541 |
| 24 | CAMKK1 | 1.82070302 |
| 25 | NTRK1 | 1.76937873 |
| 26 | DAPK1 | 1.75406545 |
| 27 | PRKD2 | 1.68702514 |
| 28 | CDK5 | 1.58891816 |
| 29 | SMG1 | 1.49795858 |
| 30 | CDK19 | 1.49369525 |
| 31 | FES | 1.49240921 |
| 32 | ICK | 1.48786036 |
| 33 | PLK2 | 1.47976583 |
| 34 | PNCK | 1.40357064 |
| 35 | GRK1 | 1.34366240 |
| 36 | PRPF4B | 1.30767532 |
| 37 | ARAF | 1.26245334 |
| 38 | SIK2 | 1.25885221 |
| 39 | MAPK13 | 1.23539069 |
| 40 | MAP3K2 | 1.20162081 |
| 41 | PRKCG | 1.19110939 |
| 42 | GRK5 | 1.19060043 |
| 43 | MAP3K13 | 1.17933833 |
| 44 | CAMKK2 | 1.17572769 |
| 45 | PKN2 | 1.14579629 |
| 46 | STK38 | 1.12440982 |
| 47 | CAMK2A | 1.07784780 |
| 48 | CAMK1 | 0.99985629 |
| 49 | TYRO3 | 0.96765052 |
| 50 | TAOK1 | 0.96678354 |
| 51 | RAF1 | 0.93509247 |
| 52 | CDK18 | 0.90319249 |
| 53 | PTK2B | 0.89494988 |
| 54 | CAMK2B | 0.89165834 |
| 55 | UHMK1 | 0.88257297 |
| 56 | CDK15 | 0.86261315 |
| 57 | CDK14 | 0.86062216 |
| 58 | STK39 | 0.84760772 |
| 59 | SGK223 | 0.83229595 |
| 60 | SGK494 | 0.83229595 |
| 61 | TSSK6 | 0.82681354 |
| 62 | MARK2 | 0.81373707 |
| 63 | PHKG1 | 0.80780384 |
| 64 | PHKG2 | 0.80780384 |
| 65 | STK11 | 0.80490772 |
| 66 | BMPR2 | 0.77548803 |
| 67 | SGK2 | 0.77459164 |
| 68 | LATS2 | 0.77148797 |
| 69 | OXSR1 | 0.76684931 |
| 70 | RET | 0.76498397 |
| 71 | SGK1 | 0.76376990 |
| 72 | PRKCH | 0.75606178 |
| 73 | CDK11A | 0.75090126 |
| 74 | SIK1 | 0.72582168 |
| 75 | CDK12 | 0.69404412 |
| 76 | DYRK1A | 0.65982841 |
| 77 | ALK | 0.65699222 |
| 78 | CSNK1A1L | 0.65557272 |
| 79 | PDK1 | 0.65502017 |
| 80 | CSNK1G2 | 0.64805777 |
| 81 | PASK | 0.64286056 |
| 82 | AKT3 | 0.63784205 |
| 83 | SGK3 | 0.63655348 |
| 84 | PAK3 | 0.63415183 |
| 85 | NME1 | 0.62891464 |
| 86 | SIK3 | 0.61177496 |
| 87 | MAP3K1 | 0.59538892 |
| 88 | PDPK1 | 0.58631434 |
| 89 | BRSK1 | 0.57596850 |
| 90 | MAP3K6 | 0.57142553 |
| 91 | MKNK2 | 0.56730178 |
| 92 | PDGFRA | 0.54779703 |
| 93 | PRKCE | 0.54132227 |
| 94 | IRAK2 | 0.52270440 |
| 95 | MTOR | 0.51325739 |
| 96 | RPS6KA3 | 0.48512403 |
| 97 | FGR | 0.48375798 |
| 98 | PRKCZ | 0.47213809 |
| 99 | PINK1 | 0.46538990 |
| 100 | NEK6 | 0.45712156 |
| 101 | MAP2K1 | 0.45652091 |
| 102 | CAMK1G | 0.44653352 |
| 103 | FYN | 0.44294543 |
| 104 | CAMK4 | 0.44056212 |
| 105 | CAMK2D | 0.43632274 |
| 106 | LMTK2 | 0.42924045 |
| 107 | CCNB1 | 0.42759843 |
| 108 | BRSK2 | 0.42600469 |
| 109 | PAK2 | 0.41853973 |
| 110 | CSNK1E | 0.41317808 |
| 111 | MAP3K11 | 0.40950098 |
| 112 | MAP3K7 | 0.40851344 |
| 113 | CAMK2G | 0.39349330 |
| 114 | NEK1 | 0.39336212 |
| 115 | WNK3 | 0.37656518 |
| 116 | WNK1 | 0.37605192 |
| 117 | DAPK3 | 0.37472066 |
| 118 | MAPK10 | 0.36951149 |
| 119 | FER | 0.36714945 |
| 120 | CDK7 | 0.36099510 |
| 121 | PRKCB | 0.34788268 |
| 122 | SCYL2 | 0.33712297 |
| 123 | BRAF | 0.33696380 |
| 124 | VRK2 | 0.32219778 |
| 125 | AURKA | 0.32123251 |
| 126 | DMPK | 0.30364969 |
| 127 | MUSK | 0.30234793 |
| 128 | BCR | 0.29128198 |
| 129 | GSK3B | 0.28165098 |
| 130 | RPS6KA2 | 0.28096437 |
| 131 | CSNK1G3 | 0.27035523 |
| 132 | PRKCI | 0.25955061 |
| 133 | PRKDC | 0.22444321 |
| 134 | PRKAA1 | 0.21312946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77989252 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.35420570 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.96028954 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.78984785 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78242977 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78055739 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75107121 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71263862 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.63453510 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62938442 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.57313316 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.25130893 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.17519868 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04400059 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01330132 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.97902995 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.84109628 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83751015 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.74801735 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74472405 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.72179246 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71313096 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69199097 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68741206 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.67850090 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65721346 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.63408193 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59605310 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58192057 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41250934 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37660264 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35812080 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35259320 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.32386679 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30911790 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30292520 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29105632 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24295029 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.17367060 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14658808 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13666215 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.12930309 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12576928 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10886905 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08551232 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07683839 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07451455 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06928091 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05631530 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04869413 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01998897 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.99550564 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99273110 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98178094 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.97798421 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97419916 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92532688 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.90884313 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90037313 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87543816 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83768373 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81819457 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.81418259 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80791721 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80691394 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80172681 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79764252 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79051527 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.76452241 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76447633 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76248382 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75814672 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75448997 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73372450 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72714191 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72344455 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71541345 |
| 78 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70967445 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70958747 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70224334 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69807316 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66704831 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63735866 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62125813 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62094414 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62052532 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61961952 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59374627 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.58763061 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58690195 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57888995 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56072839 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.55415775 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55289748 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54723298 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54553010 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53206820 |
| 98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52116612 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52019470 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.51346731 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50554554 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50517439 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50157623 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48315261 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47904864 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46753461 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45622678 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45288232 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44937300 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44867980 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44280981 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44149150 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.43633395 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41939326 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.39571073 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38847789 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.38583779 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37410189 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37247154 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36635876 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36321665 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35935729 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33525948 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33069958 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32005835 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31949511 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31574624 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31129560 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30891259 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28622118 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23624778 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22480472 |

